# Hepatocellular Carcinoma Treatment and Prognosis

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the management, diagnosis, and treatment of hepatocellular carcinoma (HCC), also known as liver cancer. It covers various aspects including clinical practice guidelines, radiofrequency ablation, use of sorafenib, liver resection, and survival rates. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10073 |
| Works | 805 |

## Topic papers all

Showing 15 of 805.

- [AASLD guidelines for the treatment of hepatocellular carcinoma](https://scholariq.org/papers/aasld-guidelines-for-the-treatment-of-hepatocellular-carcinoma/)
- [Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-patients-with-advanced-hepatocellular-carcinoma-previously/)
- [Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)](https://scholariq.org/papers/posthepatectomy-liver-failure-a-definition-and-grading-by-the-international/)
- [Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update](https://scholariq.org/papers/asia-pacific-clinical-practice-guidelines-on-the-management-of-hepatocellular/)
- [Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis](https://scholariq.org/papers/predicting-survival-after-liver-transplantation-in-patients-with-hepatocellular/)
- [Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study](https://scholariq.org/papers/standard-dose-versus-high-dose-conformal-radiotherapy-with-concurrent-and/)
- [Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-after-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma/)
- [The International Position on Laparoscopic Liver Surgery](https://scholariq.org/papers/the-international-position-on-laparoscopic-liver-surgery/)
- [Human primary liver cancer–derived organoid cultures for disease modeling and drug screening](https://scholariq.org/papers/human-primary-liver-cancer-derived-organoid-cultures-for-disease-modeling-and/)
- [Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial](https://scholariq.org/papers/radiotherapy-plus-chemotherapy-with-or-without-surgical-resection-for-stage-iii/)
- [Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy](https://scholariq.org/papers/improved-survival-in-metastatic-colorectal-cancer-is-associated-with-adoption-of/)
- [Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update](https://scholariq.org/papers/image-guided-tumor-ablation-standardization-of-terminology-and-reporting-3/)
- [Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka.](https://scholariq.org/papers/recommendations-for-laparoscopic-liver-resection-a-report-from-the-second/)
- [Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases](https://scholariq.org/papers/chemotherapy-regimen-predicts-steatohepatitis-and-an-increase-in-90-day/)
- [Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study](https://scholariq.org/papers/global-patterns-of-hepatocellular-carcinoma-management-from-diagnosis-to-death/)

## Topic primary papers

Showing 15 of 445.

- [AASLD guidelines for the treatment of hepatocellular carcinoma](https://scholariq.org/papers/aasld-guidelines-for-the-treatment-of-hepatocellular-carcinoma/)
- [Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-patients-with-advanced-hepatocellular-carcinoma-previously/)
- [Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)](https://scholariq.org/papers/posthepatectomy-liver-failure-a-definition-and-grading-by-the-international/)
- [Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update](https://scholariq.org/papers/asia-pacific-clinical-practice-guidelines-on-the-management-of-hepatocellular/)
- [Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis](https://scholariq.org/papers/predicting-survival-after-liver-transplantation-in-patients-with-hepatocellular/)
- [Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-after-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma/)
- [The International Position on Laparoscopic Liver Surgery](https://scholariq.org/papers/the-international-position-on-laparoscopic-liver-surgery/)
- [Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update](https://scholariq.org/papers/image-guided-tumor-ablation-standardization-of-terminology-and-reporting-3/)
- [Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka.](https://scholariq.org/papers/recommendations-for-laparoscopic-liver-resection-a-report-from-the-second/)
- [Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases](https://scholariq.org/papers/chemotherapy-regimen-predicts-steatohepatitis-and-an-increase-in-90-day/)
- [Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study](https://scholariq.org/papers/global-patterns-of-hepatocellular-carcinoma-management-from-diagnosis-to-death/)
- [Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study](https://scholariq.org/papers/sintilimab-plus-a-bevacizumab-biosimilar-ibi305-versus-sorafenib-in-unresectable/)
- [A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients](https://scholariq.org/papers/a-unique-metastasis-gene-signature-enables-prediction-of-tumor-relapse-in-early/)
- [Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes](https://scholariq.org/papers/radioembolization-for-hepatocellular-carcinoma-using-yttrium-90-microspheres-a/)
- [Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-consensus-recommendations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.